Skip to main content

Infections in the Immunocompromised Host

Laboratory Diagnosis and Treatment

  • Book
  • © 1986

Overview

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 202)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Bacterial and Viral Infections in the Compromised Host

  2. Fungal and Parasitic Infections in the Immunocompromised Host — An Overview

Keywords

About this book

The subject matter of this volume, the basis for which was a conference held in Philadelphia which focused on the subject of infections, including their diagnosis and treatment, in immunocompromised individuals. The material is of particular importance today when placed against the background of the rapid spread of acquired immunodeficiency syndrome (AIDS). The first section dealt with the general subject of the immunocompromised host. Here, reviewed in detail, were the epidemiological and clinical aspects of opportunistic infections in patients with defective immune responses. It is widely acknowledged that infections are a major complication of the neoplastic process. Cancer-bearing patients are more prone to certain kinds of infectious and cancer chemotherapy almost always increases susceptibility to such infections. Depending upon the basic disease process of the cancer, a specific array of infectious diseases can be predicted. Patients altered in thymus-derived lymphocyte populations or mononuclear phagocyte capabilities resulting in defects in cell mediated immunity or delayed hypersensitivity become highly susceptible to certain groups of organisms, whereas, profoundly neutropenic patients usually become infected with different organisms. The types of infections noted are relatively predictable for the type of immune defect, with some variations according to epidemiological factors. Major advances have been made in the early diagnosis and treatment of infectious complications with increasingly effective antimicrobial agents and increasing knowledge of their use. The application of so-called preventive procedures has had limited value to date, including immunotherapy, which appears to hold much promise.

Editors and Affiliations

  • Smith Kline and French Laboratories, Philadelphia, USA

    Paul Actor

  • Cooper Hospital, University Medical Center, Camden, USA

    Alan Evangelista

  • Bryn Mawr Hospital, Bryn Mawr, USA

    James Poupard

  • Rolling Hill Hospital, Elkins Park, USA

    Eileen Hinks

Bibliographic Information

  • Book Title: Infections in the Immunocompromised Host

  • Book Subtitle: Laboratory Diagnosis and Treatment

  • Editors: Paul Actor, Alan Evangelista, James Poupard, Eileen Hinks

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4684-1259-8

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 1986

  • Softcover ISBN: 978-1-4684-1261-1Published: 25 November 2012

  • eBook ISBN: 978-1-4684-1259-8Published: 06 December 2012

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XII, 208

  • Number of Illustrations: 2 b/w illustrations

  • Topics: Immunology, Medicine/Public Health, general

Publish with us